Funded Startups in Galway
Among the 25 most recent Galway-funded entries shown, one disclosed round stands far above the rest: Vivasure Medical’s $32M Series D closed on 2023-03-13,…
Among the 25 most recent Galway-funded entries shown, one disclosed round stands far above the rest: Vivasure Medical’s $32M Series D closed on 2023-03-13, while the next-highest disclosed amounts are $20M (Atlantic Therapeutics on 2022-01-20) and $17M (Luminate Medical on 2025-11-26). The smallest disclosed amount is $1M for Ronspot (Seed) on 2022-09-02, creating a wide disclosed-range from $1M to $32M with several mid-single-digit financings.
Concentration appears both in time and in classification: 7 of the 25 rounds fall between 2024-02-01 and 2024-12-06, and 17 of 25 entries are tagged “Series Unknown” or have an undisclosed amount (12 “Series Unknown” plus 2 “undisclosed” entries at Ocean Crest Marine on 2023-09-05 and Xtremedy Medical on 2023-05-29). Sector-wise, “Health Care” is the most frequent label with 11 entries, spanning from pre-seed through Series D, while other sectors such as Biotechnology (5) and AI (2) show up less often. Rounds span 2021-05-17 (spaceOS) through 2025-11-26 (Luminate Medical).
Most recent rounds
25 shownRelated listings
Frequently asked
What stands out on deal size, and how large is the disclosed outlier versus the rest of the list?
Vivasure Medical’s $32M Series D on 2023-03-13 is the only disclosed round above $20M; the next-largest disclosed amounts are $20M for Atlantic Therapeutics on 2022-01-20 and $17M for Luminate Medical on 2025-11-26.
Do the rounds cluster within a specific time window in Galway based on the most recent 25 entries shown?
Yes. Seven rounds close between 2024-02-01 (CitySwift $8M) and 2024-12-06 (NUA Surgical $7M), indicating a dense mid-to-late-2024 band compared with earlier years like 2021–2022 where amounts are more sporadic across fewer same-year datapoints.
How much of the pipeline has unclear disclosed size or round type (Series Unknown/undisclosed), and where do the disclosed exceptions show up?
Overall, 17 of 25 entries are either “Series Unknown” or marked “undisclosed” (12 “Series Unknown” plus 2 “undisclosed” entries: Ocean Crest Marine on 2023-09-05 and Xtremedy Medical on 2023-05-29). The remaining 8 entries include explicit rounds such as Series A (NUA Surgical 2024-12-06 $7M) and Series D (Vivasure Medical 2023-03-13 $32M).
Which sectors are over-represented in this Galway set, and what does that imply about where capital is flowing?
Health Care is the dominant label with 11 of 25 entries, including multiple disclosed financings like NUA Surgical ($7M, Series A on 2024-12-06) and SymPhysis Medical ($2M on 2024-10-07). Biotechnology appears in 5 entries (e.g., Luminate Medical $17M on 2025-11-26; Relevium Medical $5M on 2024-11-27), while AI appears twice (CitySwift $8M on 2024-02-01; Siren $13M on 2023-02-23).
Are there notable stage patterns across the biggest disclosed deals in this list?
Large disclosed rounds are not limited to a single stage tag: the top disclosed amount is a Series D (Vivasure Medical $32M on 2023-03-13), while other high financings include a Series Unknown round (Luminate Medical $17M on 2025-11-26) and a Venture - Series Unknown round (Atlantic Therapeutics $20M on 2022-01-20). By contrast, the smallest disclosed amount is a Seed round at $1M (Ronspot on 2022-09-02).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.